Sly L - Search Results

1

Alleviation of severe chronic arthritic pain using polyvalent immunoglobulins (KMP01): Two case reports.

Woodcock BG, Braun P, Gasser M, Sly L, Lissner R. Woodcock BG, et al. Among authors: sly l. Int J Clin Pharmacol Ther. 2024 Aug;62(8):377-385. doi: 10.5414/CP204615. Int J Clin Pharmacol Ther. 2024. PMID: 38916486

2

Laboratory safety evaluation of lokivetmab, a canine anti-interleukin-31 monoclonal antibody, in dogs.

Krautmann M, Walters RR, King VL, Esch K, Mahabir SP, Gonzales A, Dominowski PJ, Sly L, Mwangi D, Foss DL, Rai S, Messamore JE, Gagnon G, Schoell A, Dunham SA, Martinon OM. Krautmann M, et al. Among authors: sly l. Vet Immunol Immunopathol. 2023 Apr;258:110574. doi: 10.1016/j.vetimm.2023.110574. Epub 2023 Feb 21. Vet Immunol Immunopathol. 2023. PMID: 36842258 Free article.

3

Macrophage immunotherapy: overcoming impediments to realize promise.

Sly LM, McKay DM. Sly LM, et al. Trends Immunol. 2022 Dec;43(12):959-968. doi: 10.1016/j.it.2022.10.002. Epub 2022 Oct 29. Trends Immunol. 2022. PMID: 36441083 Review.

4

Evidence that oral immunoglobulins (KMP01) suppress pro-tumor inflammation in rectal carcinoma: Case report and treatment concept.

Oguz S, Buia A, Albers B, Suna K, Piroski V, Knapp A, Sly L, Döll U, Braun P, Woodcock BG. Oguz S, et al. Among authors: sly l. Int J Clin Pharmacol Ther. 2022 Dec;60(12):521-529. doi: 10.5414/CP204326. Int J Clin Pharmacol Ther. 2022. PMID: 36331015

5

Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases.

Luzentales-Simpson M, Pang YCF, Zhang A, Sousa JA, Sly LM. Luzentales-Simpson M, et al. Among authors: sly lm. Front Cell Dev Biol. 2021 Feb 3;9:612830. doi: 10.3389/fcell.2021.612830. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33614645 Free PMC article. Review.

6

COVID-19: Cytokine storm modulation/blockade with oral polyvalent immunoglobulins (PVIG, KMP01D): A potential and safe therapeutic agent (Primum nil nocere).

Sly LM, Braun P, Woodcock BG. Sly LM, et al. Int J Clin Pharmacol Ther. 2020 Dec;58(12):678-686. doi: 10.5414/CP203890. Int J Clin Pharmacol Ther. 2020. PMID: 33141018

7

Gut microbes in pediatric ALL survivorship.

Sly LM. Sly LM. Pediatr Hematol Oncol. 2020 Sep;37(6):451-454. doi: 10.1080/08880018.2020.1793850. Epub 2020 Jul 23. Pediatr Hematol Oncol. 2020. PMID: 32701381

8

FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity.

Hubbard JJ, Pyzik M, Rath T, Kozicky LK, Sand KMK, Gandhi AK, Grevys A, Foss S, Menzies SC, Glickman JN, Fiebiger E, Roopenian DC, Sandlie I, Andersen JT, Sly LM, Baker K, Blumberg RS. Hubbard JJ, et al. Among authors: sly lm. J Exp Med. 2020 Oct 5;217(10):e20200359. doi: 10.1084/jem.20200359. J Exp Med. 2020. PMID: 32658257 Free PMC article.

9

Pulmonary and systemic responses to aerosolized lysate of Staphylococcus aureus and Escherichia coli in calves.

Bassel LL, Co C, Macdonald A, Sly L, McCandless EE, Hewson J, Tiwari R, Sharif S, Siracusa L, Clark ME, Caswell JL. Bassel LL, et al. Among authors: sly l. BMC Vet Res. 2020 May 29;16(1):168. doi: 10.1186/s12917-020-02383-7. BMC Vet Res. 2020. PMID: 32471444 Free PMC article.

10

How do immune and mesenchymal cells influence the intestinal epithelial cell compartment in inflammatory bowel disease? Let's crosstalk about it!

Rees WD, Sly LM, Steiner TS. Rees WD, et al. Among authors: sly lm. J Leukoc Biol. 2020 Jul;108(1):309-321. doi: 10.1002/JLB.3MIR0120-567R. Epub 2020 Feb 14. J Leukoc Biol. 2020. PMID: 32057139 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters